455 related articles for article (PubMed ID: 19580429)
1. Molecular markers of breast axillary lymph node metastasis.
Cavalli LR
Expert Rev Mol Diagn; 2009 Jul; 9(5):441-54. PubMed ID: 19580429
[TBL] [Abstract][Full Text] [Related]
2. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.
Feng Y; Sun B; Li X; Zhang L; Niu Y; Xiao C; Ning L; Fang Z; Wang Y; Zhang L; Cheng J; Zhang W; Hao X
Breast Cancer Res Treat; 2007 Jul; 103(3):319-29. PubMed ID: 17123152
[TBL] [Abstract][Full Text] [Related]
3. Prediction of nodal metastasis and prognosis in breast cancer: a neural model.
Naguib RN; Adams AE; Horne CH; Angus B; Smith AF; Sherbet GV; Lennard TW
Anticancer Res; 1997; 17(4A):2735-41. PubMed ID: 9252707
[TBL] [Abstract][Full Text] [Related]
4. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
[TBL] [Abstract][Full Text] [Related]
5. Prediction of lymph node metastasis by gene expression profiling in patients with primary resected lung cancer.
Moriya Y; Iyoda A; Kasai Y; Sugimoto T; Hashida J; Nimura Y; Kato M; Takiguchi M; Fujisawa T; Seki N; Yoshino I
Lung Cancer; 2009 Apr; 64(1):86-91. PubMed ID: 18930562
[TBL] [Abstract][Full Text] [Related]
6. [Screening of differential expression genes between primary breast cancer and its lymph node metastasis using single primer amplification of cDNA for microarray].
Hao XS; Feng YM; Zhang L; Li XQ; Niu Y; Xiao CH; Sun BC
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):385-90. PubMed ID: 15854527
[TBL] [Abstract][Full Text] [Related]
7. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
Ross JS
Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
[TBL] [Abstract][Full Text] [Related]
8. Beyond lymph node staging: molecular predictors of outcome in breast cancer.
Sheldon DG
Surg Oncol Clin N Am; 2005 Jan; 14(1):69-84, vi. PubMed ID: 15542000
[TBL] [Abstract][Full Text] [Related]
9. A prognostic DNA signature for T1T2 node-negative breast cancer patients.
Gravier E; Pierron G; Vincent-Salomon A; Gruel N; Raynal V; Savignoni A; De Rycke Y; Pierga JY; Lucchesi C; Reyal F; Fourquet A; Roman-Roman S; Radvanyi F; Sastre-Garau X; Asselain B; Delattre O
Genes Chromosomes Cancer; 2010 Dec; 49(12):1125-34. PubMed ID: 20842727
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of sentinel lymph node micrometastasis in breast cancer.
Patani N; Mokbel K
Breast Cancer Res Treat; 2009 Apr; 114(3):393-402. PubMed ID: 18425678
[TBL] [Abstract][Full Text] [Related]
11. High-resolution genomic profiling to predict 10-year overall survival in node-negative breast cancer.
Möllerström E; Delle U; Danielsson A; Parris T; Olsson B; Karlsson P; Helou K
Cancer Genet Cytogenet; 2010 Apr; 198(2):79-89. PubMed ID: 20362222
[TBL] [Abstract][Full Text] [Related]
12. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast.
Pervez S; Khan MN; Nasir MI
J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469
[TBL] [Abstract][Full Text] [Related]
13. The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer.
Becker TE; Ellsworth RE; Deyarmin B; Patney HL; Jordan RM; Hooke JA; Shriver CD; Ellsworth DL
Ann Surg Oncol; 2008 Apr; 15(4):1056-63. PubMed ID: 18246400
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profile of primary gastric cancer: towards the prediction of lymph node status.
Marchet A; Mocellin S; Belluco C; Ambrosi A; DeMarchi F; Mammano E; Digito M; Leon A; D'Arrigo A; Lise M; Nitti D
Ann Surg Oncol; 2007 Mar; 14(3):1058-64. PubMed ID: 17106627
[TBL] [Abstract][Full Text] [Related]
15. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
[TBL] [Abstract][Full Text] [Related]
16. Predicting features of breast cancer with gene expression patterns.
Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
[TBL] [Abstract][Full Text] [Related]
17. Allelic imbalance in primary breast carcinomas and metastatic tumors of the axillary lymph nodes.
Ellsworth RE; Ellsworth DL; Neatrour DM; Deyarmin B; Lubert SM; Sarachine MJ; Brown P; Hooke JA; Shriver CD
Mol Cancer Res; 2005 Feb; 3(2):71-7. PubMed ID: 15755873
[TBL] [Abstract][Full Text] [Related]
18. New molecular classifications of breast cancer.
Cianfrocca M; Gradishar W
CA Cancer J Clin; 2009; 59(5):303-13. PubMed ID: 19729680
[TBL] [Abstract][Full Text] [Related]
19. Individualization of breast cancer based on histopathological features and molecular alterations.
Tsuda H
Breast Cancer; 2008; 15(2):121-32. PubMed ID: 18320292
[TBL] [Abstract][Full Text] [Related]
20. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
Malinowski DP
Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
